A Randomized, Open-label Study of the Effect of Adjuvant Therapy With Adriamycin Plus Cytoxan Followed by Taxotere or Taxotere Plus Xeloda on Overall Survival in Female Patients With High-risk Breast Cancer
Phase of Trial: Phase III
Latest Information Update: 11 Mar 2016
At a glance
- Drugs Capecitabine (Primary) ; Aromatase inhibitors; Cyclophosphamide; Docetaxel; Doxorubicin; Tamoxifen; Trastuzumab
- Indications Early breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jul 2011 Planned End Date changed from 1 Feb 2013 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 07 Jun 2011 Pooled analysis results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History